Premium
In Medication‐Overuse Headache, fMRI Shows Long‐Lasting Dysfunction in Midbrain Areas
Author(s) -
Ferraro Stefania,
Grazzi Licia,
Muffatti Riccardo,
Nava Simone,
Ghielmetti Francesco,
Bertolino Nicola,
Mandelli Maria Luisa,
Visintin Eleonora,
Bruzzone Maria Grazia,
Nigri Anna,
Epifani Francesca,
Bussone Gennaro,
Chiapparini Luisa
Publication year - 2012
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.2012.02276.x
Subject(s) - ventral tegmental area , ventromedial prefrontal cortex , substantia nigra , dopamine , prefrontal cortex , addiction , neuroscience , midbrain , migraine , psychology , orbitofrontal cortex , phonophobia , medicine , dopaminergic , psychiatry , central nervous system , cognition , aura
Objective. The primary aim of our study was to evaluate if a group of medication‐overuse headache ( MOH ) patients present dysfunctions in the mesocorticolimbic dopamine circuit. The secondary aim was to disentangle the role of the medication overuse and of the acute/chronic headache in determining these alterations and to investigate their persistence. Background. Several researches have suggested that MOH may belong to the spectrum of addictive behavior. Preclinical models and neuroimaging studies have consistently demonstrated that in addiction, critical long‐lasting alterations occur in the mesocorticolimbic dopamine circuit. If MOH shares some neurophysiological features with addiction, long‐lasting functional alterations of the mesocorticolimbic dopamine system related to medication overuse should be present. Methods. We collected functional magnetic resonance imaging data during the execution of a decision‐making under risk paradigm in 8 MOH patients immediately after beginning medication withdrawal, in 8 detoxified MOH patients at 6 months after beginning medication withdrawal, in 8 chronic migraine patients, and in 8 control subjects. Results. Our results revealed that MOH patients present: (1) reduced task‐related activity in the substantia nigra/ventral tegmental area complex and increased activity in the ventromedial prefrontal cortex, when compared with controls; (2) reduced activity in the substantia nigra/ventral tegmental area complex, when compared with chronic migraine patients; (3) increased activity in the ventromedial prefrontal cortex, when compared with detoxified MOH patients. Conclusion. Our study showed that MOH patients present dysfunctions in the mesocorticolimbic dopamine circuit, in particular in the ventromedial prefrontal cortex and in the substantia nigra/ventral tegmental area complex. The ventromedial prefrontal cortex dysfunctions seem to be reversible and attributable to the acute/chronic headache, whereas the substantia nigra/ventral tegmental area complex dysfunctions are persistent and possibly related to medication overuse. These dysfunctions might be the expression of long‐lasting neuroadaptations related to the overuse of medications and/or a pre‐existing neurophysiological condition leading to vulnerability to medication overuse. The observed persistent dysfunctions in the midbrain dopamine suggest that MOH may share some neurophysiological features with addiction.